AIM
IMCR icon

AXA Investment Managers’s Immunocore IMCR Stock Holding History

AXA Investment Managers’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.46M Buy
+95,172
New +$3.23M 0.01% 650

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AXA Investment Managers's IMCR Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Immunocore (IMCR) in Q3 2025: 95,172 shares worth $3.46M. The stake represents 0.01% of the portfolio and ranks #650 among its holdings.

132 funds tracked by Wall St. Rank hold IMCR as of Q3 2025.

  • AXA Investment Managers held 95,172 shares of Immunocore worth $3.46M as of Q3 2025.
  • Immunocore was a new AXA Investment Managers position in Q3 2025.
  • Immunocore made up 0.01% of AXA Investment Managers's portfolio in Q3 2025, its #650 holding.
  • 132 funds tracked by Wall St. Rank held Immunocore as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.